CITIGROUP INC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,005,019
+144.0%
157,462
+150.9%
0.01%
+133.3%
Q2 2023$4,509,790
+51.3%
62,758
+29.9%
0.00%
+50.0%
Q1 2023$2,980,501
-4.8%
48,322
+19.0%
0.00%0.0%
Q4 2022$3,131,324
+45.0%
40,598
-16.1%
0.00%0.0%
Q3 2022$2,159,000
-49.6%
48,405
-56.7%
0.00%
-50.0%
Q2 2022$4,280,000
+1056.8%
111,746
+1155.0%
0.00%
Q1 2022$370,000
-20.3%
8,904
-27.5%
0.00%
Q4 2021$464,000
-70.0%
12,284
-73.8%
0.00%
-100.0%
Q3 2021$1,545,000
+201.8%
46,871
+518.2%
0.00%
Q2 2021$512,000
+51.5%
7,582
+26.9%
0.00%
Q1 2021$338,000
-88.7%
5,974
-83.8%
0.00%
-100.0%
Q4 2020$3,004,000
-17.1%
36,871
-27.5%
0.00%
-33.3%
Q3 2020$3,623,000
-81.6%
50,847
-78.7%
0.00%
-80.0%
Q2 2020$19,688,000
+2712.6%
239,267
+1911.7%
0.02%
+1400.0%
Q1 2020$700,000
-18.8%
11,894
+42.5%
0.00%0.0%
Q4 2019$862,000
+1590.2%
8,347
+232.7%
0.00%
Q3 2019$51,000
+5000.0%
2,509
+11304.5%
0.00%
Q2 2019$1,000
-99.6%
22
-99.9%
0.00%
Q1 2019$265,00018,612
+1861100.0%
0.00%
Q2 2017$01
-97.4%
0.00%
Q1 2017$0
-100.0%
39
-98.9%
0.00%
Q4 2016$23,000
+228.6%
3,445
+277.7%
0.00%
Q3 2016$7,000
-12.5%
912
-18.6%
0.00%
Q2 2016$8,0001,1210.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,009,799$82,268,00041.24%
Fairmount Funds Management LLC 220,098$17,931,0006.41%
WMS Partners, LLC 250,000$20,368,0003.51%
IRIDIAN ASSET MANAGEMENT LLC/CT 2,064,158$168,167,0003.06%
MORGAN JESS S & CO INC 44,468$3,623,0002.88%
RTW INVESTMENTS, LP 1,672,416$136,252,0002.29%
RA Capital Management 1,655,447$134,869,0001.88%
Nicholas Investment Partners, LP 207,452$16,901,0001.30%
Affinity Asset Advisors, LLC 25,000$2,037,0001.08%
Parkman Healthcare Partners LLC 30,758$2,506,0000.64%
View complete list of AXSOME THERAPEUTICS INC shareholders